Adoptive T-cell therapy for cancer: The era of engineered T cells-Reference-Cited by-同舟云学术

Adoptive T-cell therapy for cancer: The era of engineered T cells

Published:2015-08-21 Issue:9 Volume:45 Page:2457-2469
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Bonini Chiara¹,Mondino Anna²

Affiliation:

1. Experimental Hematology Unit; Division of Immunology; Transplantation and Infectious Diseases; San Raffaele Scientific Institute; Milan Italy

2. Lymphocyte Activation Unit; Division of Immunology; Transplantation and Infectious Diseases; San Raffaele Scientific Institute; Milan Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Fifth Framework Programme

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201545552/fullpdf

Reference133 articles.

1. Exploiting the curative potential of adoptive T-cell therapy for cancer;Hinrichs;Immunol. Rev.,2014

2. Experts’ considerations on HLA-haploidentical stem cell transplantation;Patriarca;Eur. J. Haematol.,2014

3. Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation;Storb;J. Clin. Oncol.,2013

4. T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation;Vago;Blood,2012

5. Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation;Crucitti;Leukemia,2014

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in CAR-NK cell therapy for lung cancer: is it a better choice in the future?;Frontiers in Oncology;2024-05-28

2. Pediatric Solid Cancers: Dissecting the Tumor Microenvironment to Improve the Results of Clinical Immunotherapy;International Journal of Molecular Sciences;2024-03-12

3. Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT;Bone Marrow Transplantation;2024-03-04

4. Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies;Life Sciences;2024-02

5. Chimeric Antigen Receptor T-cell Therapy in Cancer: A Critical Review;Current Drug Research Reviews;2023-11